BIOBANK
Biobank is a disposable medical supplies developer company.
BIOBANK
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2014-10-15
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.inno-spring.com
Total Employee:
11+
Status:
Active
Contact:
0571-87605135
Email Addresses:
[email protected]
Total Funding:
3 M CNY
Technology used in webpage:
Euro Pound Sterling Japanese Yen Tencent QQ Mail
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
SyMap Medical
SyMap Medical is an innovative medical device company.
Investors List
Fenghui Consulting
Fenghui Consulting investment in Angel Round - Biobank
More informations about "Biobank"
Clinical hematopoietic stem cell-based gene therapy
Jun 4, 2025 Hematopoietic stem cell (HSC)-based gene therapies have seen extraordinary progress since their initial conception, now fundamentally transforming the treatment โฆSee details»
Cell Therapy: Types, Regulation, and Clinical Benefits
Nov 22, 2021 Cell therapy practices date back to the 19 th century and continue to expand on investigational and investment grounds. Cell therapy includes stem cell- and nonโstem cell โฆSee details»
CAR T-Cell-Based gene therapy for cancers: new perspectives
Jul 22, 2022 Chimeric antigen receptor (CAR)-T cell therapy is a progressive new pillar in immune cell therapy for cancer. It has yielded remarkable clinical responses in patients with B โฆSee details»
Autologous Stem-Cell-Based Gene Therapy for Inherited Disorders: State ...
Abstract Gene therapy using patient's own stem cells is rapidly becoming an alternative to allogeneic stem cell transplantation, especially when suitably compatible donors cannot be โฆSee details»
U.S. FDA Approves ZEVASKYNโข (prademagene zamikeracel), the โฆ
Apr 29, 2025 The Companyโs fully integrated cell and gene therapy cGMP manufacturing facility in Cleveland, Ohio serves as the manufacturing site for ZEVASKYN commercial production. โฆSee details»
Gene and cell therapy of human genetic diseases: Recent โฆ
Sep 8, 2024 1 INTRODUCTION TO GENE AND CELL THERAPY The malfunction of vital genes in the body can lead to disruptions in normal development and the emergence of various โฆSee details»
FDA Approves First Cell-Based Gene Therapy for Adult Patients โฆ
FDA approved the first cell-based gene therapy to treat adults with multiple myeloma who have tried at least four prior different types of therapy.See details»
What is gene and cell therapy? - EuroGCT
In recent decades, cell and gene therapy has developed from a hypothesis to a life-saving reality. But what do we mean when we talk about gene and cell therapy?See details»
The state of cell and gene therapy in 2023
Dec 6, 2023 In early 2023, there were more than 100 different approved gene, cell, and RNA therapies throughout the world, with over 3,700 more in clinical and preclinical development. โฆSee details»
Engineering the next generation of cell-based therapeutics
The widespread clinical translation and commercialization of cell-based therapies are hampered by challenges related to cell source, viability, potency, safety and scalability. Here, Veiseh and โฆSee details»
The current state of Cytotherapy and the field of cell and gene therapy
Jan 16, 2025 Cell and gene therapy (CGT) saw a significant inflection point in growth in 2024. The year was characterized by notable scientific advancements, regulatory approvals and โฆSee details»
From bench to bedside: the future of stable lentiviral packaging cell ...
Apr 26, 2025 The past decade has marked a significant milestone for the field of gene therapy. With CAR-T and CRISPR therapy taking center stage, the US Food and Drug Administration โฆSee details»
Cellular Therapies Program | Dana-Farber Cancer Institute
The Connell and OโReilly Families Cell Manipulation Core Facility (CMCF) at Dana-Farber Cancer Institute is a state-of-the-art academic GMP laboratory dedicated to the production of cellular โฆSee details»
Cell & Gene Therapies in 2025: Breakthroughs, Challenges, and โฆ
Jul 1, 2025 The CMS is also preparing to launch a new voluntary Cell and Gene Therapy Access Model to improve access to these therapies for low-income patients in the US public health โฆSee details»
RNA and epigenetic editing: The new frontier in gene and cell therapy
Feb 5, 2025 Over the past two decades, the field of gene and cell therapy has been revolutionized by the advent of CRISPR-Cas9 genome editing.1,2 This technology has โฆSee details»
Cell-based therapy technology classifications and translational ...
Illustration of cell-technology classification in relation to potential therapeutic use. Key: long arrow towards the human body indicates an autologous approach; short arrows indicate the potential โฆSee details»
Cell Based Therapy Laboratory - Children's Hospital of Philadelphia
The Cell Based Therapy Laboratory (CBTL, formerly called Cell and Gene Therapy Lab or CGTL) has been at the forefront of pediatric healthcare innovation for decades. Transitioning from our โฆSee details»
Cell, Tissue and Gene Therapy Products - World Health โฆ
Jul 10, 2024 Cell, tissue, and gene therapy products represent a highly diverse range of medicinal products which continues to expand as the technology develops and matures.See details»
U.S. FDA Approves ZEVASKYNโข (prademagene zamikeracel), the
Apr 29, 2025 ZEVASKYN is the first and only autologous cell sheet-based gene therapy for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis โฆSee details»
Innovative Therapies: How Cell & Gene Technologies Change Lives
Discover how innovative cell and gene therapies are revolutionizing medical treatments, offering new hope for genetic disorders, cancer, and chronic diseases.See details»